SWARTZ ROBIN (Chief Operating Officer) sold 3.4% of their position (2.54K shares) of VOYAGER THERAPEUTICS, INC. on the open market
Open‑market sale worth $18.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/19/2024ACC: 0001104659-24-005247
Officer· Chief Operating Officer
Since Feb 2022
-2.54K
Net shares
Net seller
$18.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.54K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.54K
Price / share
$7.15
Trade value
$18.18K
% of position
3.4%
1/17/2024
74.87K→72.33K
Total
Net shares
−2.54K
Net value
-$18.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/17/2024 | S · Sale | −2.54K | $7.15 | $18.18K | 3.4% | 74.87K | 72.33K |
| Total | −2.54K | -$18.18K | ||||||
Derivative Transactions0
No derivative transactions reported